Noritsu America completes acquisition of Lucidiom
BUENA PARK, Calif. A global manufacturer of professional digital imaging equipment has completed the acquisition of Vienna, Va.-based brand-independent photo kiosk provider.
Noritsu America Corp. said it has completed its acquisition of Lucidiom. The relationship offers photo services retailers of all sizes a complete imaging solution that creates new revenue streams for photo department growth and profitability in the rapidly expanding social expression age, Noritsu said.
“Retailers looking for ways to enhance the profit opportunities from their photo services department now have an integrated and scalable photo solution for the consumer driven digital age,” said Steven L’Heureux, Noritsu America COO. “What we are offering retailers is the opportunity to combine the resources of our superior digital imaging equipment, already deployed in more than 50 percent of the nation’s leading retailers, with Lucidiom’s creative APM [automated photo machine] kiosks and versatile Web-based solutions.”
L’Heureux said that with Lucidiom’s established network of more than 55,000 APM kiosks and Noritsu’s market leadership in printing solutions, the companies together will provide retailers a proven and highly integrated photo solution that can generate new revenue streams and improved gross margins in their photo departments.
Actavis goes up for sale, peaks interest of major Rx companies
NEW YORK Icelandic generic drug maker Actavis is for sale and could go for up to $10.8 billion at a time when many generic drug companies find themselves targets of acquisitions.
The fifth largest maker of generic drugs in the world, Actavis became a private company in 2007 after action by majority stakeholder Novator, led by Icelandic billionaire Thor Bjorgolfsson.
According to Reuters, a number of large drug makers could end up buying the company, including Pfizer, Sanofi-Aventis, GlaxoSmithKline and Novartis.
In other news, the Food and Drug Administration announced Friday that it had filed a consent decree and was awaiting the United States District Court for the District of New Jersey’s entry of a permanent injunction forbidding Actavis’ U.S. subsidiary, Actavis Totowa, from manufacturing drugs in its New Jersey factories until the FDA decides the factories are in compliance with current good-manufacturing practice requirements.
Winn-Dixie opens prototype store with expanded grocery departments, pharmacy
JACKSONVILLE, Fla. Winn-Dixie Stores on Wednesday opened a prototype store in its existing SaveRite location here featuring everyday low pricing on thousands of items a la Walmart, as well as monthly locked-in specials and special price-drop items in a warehouse format.
“In designing this concept, we spent a great deal of time reviewing our customers’ shopping preferences,” said Dan Portnoy, Winn-Dixie chief merchandising and marketing officer. “We wanted to make sure that the new store would be a true fit for the neighborhoods it serves. … We focused only on those items and services that were most important to our customers, and, as a result, we were able to aggressively cut costs and lower prices throughout the store.”
In addition to enhanced produce and meat departments, the 48,000-square-foot store also has an in-store pharmacy where customers will find 30-day supplies of more than 400 generic drugs for only $3.98 every day. Other features include newly designed warehouse-style shopping carts and popular staple items available for purchase by the case.
SaveRite closed the store Jan. 6, allowing time for associates to work through the afternoon and evening to lower thousands of prices. The company welcomed area leaders and residents to a preview on Tuesday evening where SaveRite donated $5,000 to Paxon Improvement Association. To celebrate the store’s new format, SaveRite will also host a Family Fun Event on Jan. 10.